Porton Pharma Solutions Ltd. (SHE:300363)
China flag China · Delayed Price · Currency is CNY
23.79
+0.42 (1.80%)
Feb 3, 2026, 3:04 PM CST

Porton Pharma Solutions Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
12,6248,60213,73522,30548,69719,821
Market Cap Growth
51.06%-37.37%-38.42%-54.20%145.68%155.21%
Enterprise Value
13,1779,40313,24920,59848,16818,944
Last Close Price
23.3715.7724.3438.2483.5234.02
PE Ratio
--51.4711.1292.9561.10
Forward PE
101.6154.1427.0712.6371.8551.44
PS Ratio
3.682.863.753.1715.689.57
PB Ratio
2.301.592.253.4511.635.84
P/TBV Ratio
2.631.852.624.1313.646.48
P/FCF Ratio
73.20--16.03-179.53
P/OCF Ratio
23.4921.2121.838.70101.4239.30
PEG Ratio
-0.760.760.760.760.76
EV/Sales Ratio
3.843.123.612.9315.519.14
EV/EBITDA Ratio
25.4498.0522.828.4066.9138.06
EV/EBIT Ratio
133.19-45.399.2986.6551.66
EV/FCF Ratio
76.40--14.81-171.59
Debt / Equity Ratio
0.310.360.320.140.180.07
Debt / EBITDA Ratio
3.3311.403.080.370.990.50
Debt / FCF Ratio
9.99--0.66-2.28
Asset Turnover
0.390.330.380.840.560.49
Inventory Turnover
3.313.102.764.103.113.20
Quick Ratio
1.381.371.941.471.121.72
Current Ratio
1.871.902.631.811.522.22
Return on Equity (ROE)
-1.35%-6.36%2.79%36.34%12.55%10.01%
Return on Assets (ROA)
0.71%-1.54%1.87%16.59%6.28%5.42%
Return on Invested Capital (ROIC)
1.68%-3.73%3.90%46.32%15.82%14.12%
Return on Capital Employed (ROCE)
1.40%-3.20%3.70%31.10%12.50%10.40%
Earnings Yield
-0.01%-3.35%1.94%8.99%1.08%1.64%
FCF Yield
1.37%-0.99%-3.65%6.24%-0.61%0.56%
Dividend Yield
--2.00%2.89%0.23%0.36%
Payout Ratio
--234.79%6.44%15.80%25.44%
Buyback Yield / Dilution
1.59%0.31%-0.21%-0.62%0.11%-1.99%
Total Shareholder Return
1.59%0.31%1.79%2.27%0.34%-1.63%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.